Skip to main content
Premium Trial:

Request an Annual Quote

Osmetech to Run Qiagen Respiratory Test on MDx Platform

NEW YORK (GenomeWeb News) – Osmetech said today that it will adapt a Qiagen respiratory viral test for use on its eSensor XT-8 molecular diagnostics system.
Qiagen will supply Osmetech with its QIAplex-based reagents for the multiplex amplification of the most common viruses associated with respiratory infections. UK-based Osmetech said that it will develop an in vitro diagnostic test for use on its molecular diagnostics platform and submit the test for US Food and Drug Administration clearance.
This past summer, Qiagen launched its QIAplex-based ResPlex II respiratory panel for research use only. The panel enables detection of up to 17 different viral molecular targets, including influenza A/B and parainfluenza RSV A/B.
“This is an excellent opportunity to take an already commercially successful product into the mainstream diagnostics market,” Osmetech CEO James White said in a statement.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.